Quantcast
Last updated on April 20, 2014 at 8:28 EDT

Latest Dopamine agonists Stories

2009-08-17 08:33:00

The U.S. Food and Drug Administration announced the recall of a Barr Laboratories Inc. amphetamine product because of a health hazard. The FDA said the dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate and amphetamine sulfate 20mg mixed amphetamine salt tablets are being recalled because some might exceed weight requirements, resulting in super-potency. The federal agency said potential adverse reactions to a supratherapeutic dose could include cardiovascular,...

2009-08-04 08:00:00

SALT LAKE CITY, Aug. 4 /PRNewswire/ -- RIESTER creative from Utah's End Meth Now campaign has been selected by the Office of National Drug Control Policy (ONDCP) to become a key resource to states across the country in the fight against meth use. In contrast to other approaches combating meth addiction, the End Meth Now campaign inspires hope and enlists the help of loved ones in fighting the drug. "We've had the privilege of working on many successful campaigns, but feel extremely proud...

2009-07-07 23:39:31

With patience, there is hope for recovery from methamphetamine addiction, U.S. researchers say. The study, published in the Journal of Substance Abuse Treatment, says it takes at least one year for former methamphetamine users to regain cognitive functions like impulse control and attentional focus. We used to think most, if not all, effects of meth addiction were permanent, lead study author Ruth Salo of the University of California, Davis, said in a statement. This study adds to the...

2009-06-29 14:22:21

 In a study published online by the Journal of Substance Abuse Treatment, UC Davis researchers report that it takes at least a year for former methamphetamine users to regain impulse control. The results tell recovering substance abusers, their families and drug-treatment specialists that it can take an extended period of time for the brain functions critical to recovery to improve."Recovery from meth abuse does not happen overnight," said Ruth Salo, lead author of the study and a UC...

2009-05-06 12:33:00

Methamphetamine Use Drops While Amphetamine Use Continues to Rise Random Drug Testing Programs May Deter Use, Data Show MADISON, N.J., May 6 /PRNewswire/ -- Cocaine use among U.S. employees and job applicants in the general U.S. workforce declined sharply in 2008, according to the annual Quest Diagnostics Drug Testing Index(TM) (DTI), based on 5.7 million urine drug tests performed last year by Quest Diagnostics (NYSE: DGX), the nation's leading provider of drug testing services. In...

2009-05-06 16:00:18

Cocaine use among U.S. workers and job applicants dropped significantly in 2008, a private diagnostic research company said Wednesday. The annual Quest Diagnostics Drug Testing Index, compiled by Quest Diagnostics, said cocaine and methamphetamine use declined sharply, although amphetamine use increased, possibly due to increased prescriptions for Attention Deficit Disorder. Based on 5.7 million urine samples, cocaine use in the U.S. workforce dropped 29 percent last year compared to 2007....

2009-04-30 11:36:38

 In a study that reveals the clearest picture to date of neuron death in Parkinson's disease, researchers at Columbia University Medical Center have found that a trio of culprits acting in concert is responsible for killing the brain cells.The study, published in the April 30 issue of Neuron, showed that three molecules "“ the neurotransmitter dopamine, a calcium channel, and a protein called alpha-synuclein "“ act together to kill the neurons.The discovery gives researchers...

2009-04-09 07:12:49

Mayo Clinic study identifies at-risk patients A new study conducted at Mayo Clinic reports that one in six patients receiving therapeutic doses of certain drugs for Parkinson's disease develops new-onset, potentially destructive behaviors, notably compulsive gambling or hypersexuality.The study extends findings from two Mayo case series published in 2005 that reported a connection between dopamine agonist medications and compulsive gambling or hypersexuality.Dopamine agonists are a class of...

2009-04-08 11:19:00

Mayo Clinic Study Identifies At-Risk Patients At-A-Glance *Parkinson's drug may cause destructive behaviors *The patients affected are taking a therapeutic dose of the drug *Decreasing the dosage may eliminate the problem ROCHESTER, Minn., April 8 /PRNewswire-USNewswire/ -- A new study conducted at Mayo Clinic reports that one in six patients receiving therapeutic doses of certain drugs for Parkinson's disease develops new-onset, potentially destructive behaviors, notably compulsive...

2009-03-04 07:00:00

Surveyed Neurologists and PCPs Vary in Their Prescribing Patterns of Levodopa/Carbidopa and Dopamine Agonists, According to a New Report from Decision Resources WALTHAM, Mass., March 4 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that second-line patient share of MAO-B inhibitors has increased from 14.1 percent to 35.2 percent since last year's report. Most of this increased patient share...